Guggenheim lowered the firm’s price target on Accenture (ACN) to $335 from $360 and keeps a Buy rating on the shares. Fiscal Q3 results came in ahead of expectations, helped in part by foreign exchange rates, but “investors will be quick to note that F3Q25 was never in question,” the analyst stated. Broader commentary did little to ease investor concerns that FY26 expectations remain too high, adds the analyst, who notes that the firm’s FY26 estimates remain below consensus as it expects Accenture Federal Services to continue being a growth headwind. However, the firm remains constructive on Accenture shares over the medium-term as it continues to see the company benefiting from delivering on clients’ cost optimization initiatives and transformational agendas.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACN:
- Accenture price target lowered to $325 from $355 at BMO Capital
- ‘Strategic Differentiator’ Accenture Ready to Reap AI Demand
- Accenture price target lowered to $360 from $390 at Barclays
- Accenture’s Mixed Performance: Hold Rating Amid Growth Concerns and Strategic Strengths
- Accenture’s Earnings Call Highlights Robust Growth